LEF1 and COVID-19: Among the lncRNAs, HCG18-family lncRNAs, lncCEACAM21, and LEF1-AS1-202 lncRNAs are downregulated in the PBMCs of non-surviving COVID-19 patients compared to surviving ones, as well as in critical compared to severe patients, thus emerging as potential candidates for discriminating severity and predicting mortality rates in hospitalized COVID-19 patients [24].